Cancer vaccines

Myeloid derived suppressor cells – a new therapeutic target in the treatment of cancer
Robert Wesolowski, Joseph Markowitz, William E Carson

Journal for ImmunoTherapy of Cancer Dec 2013, 1 (1) 10; DOI: 10.1186/2051-1426-1-10
Cellular immunity induced by a recombinant adenovirus- human dendritic cell vaccine for melanoma
Hadas Prag Naveh, Lazar Vujanovic, Lisa H Butterfield

Journal for ImmunoTherapy of Cancer Dec 2013, 1 (1) 19; DOI: 10.1186/2051-1426-1-19
Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)
Paolo A. Ascierto, James Brugarolas, Luigi Buonaguro, Lisa H. Butterfield, David Carbone, Bruno Daniele, Robert Ferris, Bernard A. Fox, Jérôme Galon, Cesare Gridelli, Howard L. Kaufman, Christopher A. Klebanoff, Ignacio Melero, Paul Nathan, Chrystal M. Paulos, Marco Ruella, Ryan Sullivan, Hassane Zarour, Igor Puzanov

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 69; DOI: 10.1186/s40425-018-0377-z
Highlights of the 31st annual meeting of the Society for Immunotherapy of Cancer (SITC), 2016
James L. Gulley, Elizabeth A. Repasky, Laura S. Wood, Lisa H. Butterfield

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 55; DOI: 10.1186/s40425-017-0262-1
Vaccination with inhibin-α provides effective immunotherapy against testicular stromal cell tumors
Robert Aguilar, Justin M. Johnson, Patrick Barrett, Vincent K. Tuohy

Journal for ImmunoTherapy of Cancer Dec 2017, 5 (1) 37; DOI: 10.1186/s40425-017-0237-2
Immunoglobulin-like transcript 2 (ILT2) is a biomarker of therapeutic response to oncolytic immunotherapy with vaccinia viruses
Andrew Zloza, Dae Won Kim, Seunghee Kim-Schulze, Michael C Jagoda, Vladia Monsurro, Francesco M Marincola, Howard L Kaufman

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 1; DOI: 10.1186/2051-1426-2-1

Log in using your username and password

Main menu

Log in using your username and password

You are here

Cancer vaccines